These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 9511196)
1. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196 [TBL] [Abstract][Full Text] [Related]
2. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Elhelw B; Ghorab MN; Farrag SH Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051 [TBL] [Abstract][Full Text] [Related]
3. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. Hann LE; Gretz EM; Bach AM; Francis SM AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858 [TBL] [Abstract][Full Text] [Related]
4. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
5. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435 [TBL] [Abstract][Full Text] [Related]
6. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
8. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887 [TBL] [Abstract][Full Text] [Related]
9. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study. Fong K; Causer P; Atri M; Lytwyn A; Kung R Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649 [TBL] [Abstract][Full Text] [Related]
10. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen. Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880 [TBL] [Abstract][Full Text] [Related]
12. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
13. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen. Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237 [TBL] [Abstract][Full Text] [Related]
14. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080 [TBL] [Abstract][Full Text] [Related]
15. [Value of saline infusion sonohysterography and hysteroscopy in postmenopausal patient with persistent abnormal ultrasonographic images after endometrial curettage with normal histological results]. Ludwin A; Pityński K; Szczudrawa A; Biernat I; Loster J Ginekol Pol; 2003 Sep; 74(9):786-92. PubMed ID: 14674125 [TBL] [Abstract][Full Text] [Related]
16. Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium > 5 mm. Epstein E; Ramirez A; Skoog L; Valentin L Ultrasound Obstet Gynecol; 2001 Aug; 18(2):157-62. PubMed ID: 11529998 [TBL] [Abstract][Full Text] [Related]
17. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875 [TBL] [Abstract][Full Text] [Related]
18. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306 [TBL] [Abstract][Full Text] [Related]
19. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen. Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782 [TBL] [Abstract][Full Text] [Related]
20. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]